Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease

Verwendung von inhibitorn der n-methyltransferasen in der therapie des parkinson-symdroms

Utilisation d'inhibiteurs de n-methyltransferases dans la therapie de la maladie de parkinson

Abstract

Die vorliegende Erfindung betrifft die Verwendung von Hemmstoffen verschiedener N-Methyltrans-f erasen in der Therapie des Parkinson-Syndroms, insbesondere des Idiopathischen Parkinson-Syndroms.
The invention relates to the use of inhibitors of different N-methyl transferases for the therapy of Parkinson's disease, in particular of the idiopathic Parkinson's disease.
Utilisation d'inhibiteurs de différentes N-méthyltransférases dans la thérapie de la maladie de Parkinson, en particulier de la maladie de Parkinson idiopathique.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (7)

    Publication numberPublication dateAssigneeTitle
    US-2003119750-A1June 26, 2003Hans-Ulrich Demuth, Torsten Hoffmann, Konrad Glund, Ulrich Heiser, Hoersten Stephan VonUse of dipeptidyl peptidase IV inhibitors
    US-2004005304-A1January 08, 2004Mak Wood, Inc.Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
    US-2004087487-A1May 06, 2004Gluckman Peter D., Jian Guan, Tajrena AlexiRegulation of tyrosine hydroxylase by gpe
    US-6815425-B1November 09, 2004The United States Of America As Represented By The Secretary Of The ArmyPharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
    WO-0130346-A1May 03, 2001The Victoria University Of ManchesterTreatment of dyskinesia
    WO-03035675-A1May 01, 2003Liesi PaeiviPeptides actifs biologiquement et leur utilisation dans la reparation de nerfs endommages
    WO-2004069175-A2August 19, 2004Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human ServicesMethodes et compositions de traitement de la maladie de parkinson et d'autres $g(a)-synucleinopathies

NO-Patent Citations (5)

    Title
    See also references of EP 1917006A2
    STORCH ALEXANDER ET AL: "Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: Studies using heterologous expression systems of the dopamine transporter" BIOCHEMICAL PHARMACOLOGY, Bd. 63, Nr. 5, 1. März 2002 (2002-03-01), Seiten 909-920, XP002434492 ISSN: 0006-2952
    WILHELM C ET AL: "Further purification and isolation of an N-methyltransferase inhibitor with possible significance in the pathomechanism of the idiopathic Parkinson syndrome." NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, Bd. 367, Nr. Supplement 1, März 2003 (2003-03), Seite R133, XP002434494 & 44TH SPRING MEETING OF THE DEUTSCHE GESELLSCHAFT FUER EXPERIMENTELLE UND KLINISCHE PHARMAKOLOGIE UND; MAINZ, GERMANY; MARCH 17-20, 2003 ISSN: 0028-1298
    WILHELM C ET AL: "Purification and characterisation of an N-Methyltransferase inhibitor from rabbit liver" NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, Bd. 363, Nr. 4 Supplement, 2001, Seite R142, XP009083992 & 42ND SPRING MEETING OF THE GERMAN SOCIETY FOR EXPERIMENTAL AND CLLINICAL PHARMACOLOGY AND TOXICOLOGY; MAINZ, GERMANY; MARCH 13-15, 2001 ISSN: 0028-1298
    WILHELM CHR ET AL: "Further purification and characterization of an N-methyl-transferase inhibitor with possible significance in the pathomechanism of the Idiopathic Parkinson syndrome" NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, Bd. 365, Nr. Supplement 1, März 2002 (2002-03), Seite R130, XP002434493 & 43RD SPRING MEETING OF THE GERMAN SOCIETY FOR EXPERIMENTAL AND CLINICAL PHARMACOLOGY AND TOXICOLOGY; MAINZ, GERMANY; MARCH 12-14, 2002 ISSN: 0028-1298

Cited By (7)

    Publication numberPublication dateAssigneeTitle
    CN-102573854-AJuly 11, 2012普罗耶克托生物医学Cima有限公司5’-甲硫腺苷的神经保护特性
    US-2012083464-A1April 05, 2012Proyecto De Biomedicina Cima, S.L.Neuroprotective properties of 5'-methylthioadenosine
    US-7893095-B2February 22, 2011Trigendo Sp. Z O.O.Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection
    US-8247403-B2August 21, 2012Takeda Pharmaceutical Company LimitedBenzoxazepine derivatives and use thereof
    US-8377972-B2February 19, 2013Trigendo Sp. zo.o.Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection
    WO-2008104920-A1September 04, 2008Trigendo Sp. Z O.O.Utilisation de composés de pyridinium quaternaires pour la vasoprotection et/ou l'hépatoprotection
    WO-2010142827-A1December 16, 2010Proyecto De Biomedicina Cima, S. L.Propriétés neuroprotectrice de la 5'-méthylthioadénosine